Among adults with COPD and type 2 inflammation, having a history of cardiovascular or metabolic disease did not change ...

Merck completes $10B acquisition of Verona Pharma, adding Ohtuvayre — the first new inhaled COPD therapy in over 20 years.

After 1 year of biologic therapy, admissions requiring noninvasive ventilation among patients with COPD and type 2 ...

Inhalers for asthma and COPD generate substantial greenhouse gas emissions; UCLS researchers quantify carbon footprint in the ...

Areas that voted Reform also had the highest proportion of people suffering from heart disease, depression, diabetes and ...

Create a free account or Log in.

Merck & Co. Inc. (NYSE:MRK) is one of the best growth stocks to buy now. On October 7, Merck & Co. announced the completion ...

When breathing becomes a daily battle, even the simplest acts can feel exhausting. Now, a new study has found the key to ...